- Home
- SYBX vs RBNE Comparison
SYBX vs RBNE Comparison
Compare SYBX & RBNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SYBX | RBNE |
|---|---|---|
| Founded | N/A | 2024 |
| Country | United States | Cyprus |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2M | 15.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SYBX | RBNE |
|---|---|---|
| Price | $1.13 | $0.82 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 32.7K | ★ 332.9K |
| Earning Date | 11-13-2025 | 10-23-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.90 | $0.67 |
| 52 Week High | $1.96 | $24.65 |
Technical Indicators
Market Signals| Indicator | SYBX | RBNE |
|---|---|---|
| Relative Strength Index (RSI) | 20.66 | N/A |
| Support Level | $1.58 | N/A |
| Resistance Level | $1.73 | N/A |
| Average True Range (ATR) | 0.09 | 0.00 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 7.58 | 0.00 |
Price Performance
Historical ComparisonAbout SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
About RBNE Robin Energy Ltd. Common Stock
Robin Energy Ltd operates a tanker vessel that engages in the transportation of refined petroleum products using its Handysize product tanker.